Screener / SEC EDGAR /CIK 0001840856 /10-K filed Mar 2, 2026, compared with Mar 11, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Soundhound AI, Inc. SOUN

Compare with peers Embed
Planned sales, announced before they happen

14 trading plans running, 23 Form 144 notices for $9.9M

10-Q, 10-K and Form 144
Plans running now 14 •Michael Zagorsek, •Majid Emami, •Dr. Keyvan Mohajer, •James M. Hom, •Diana Sroka, •Eric Ball, •Nitesh Sharan
Plans adopted 45 reported since May 12, 2023 Form 144 notices 23 $9.9M the sellers expected to sell

What SOUN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 9, 2026 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
•Michael Zagorsek
Chief Operating Officer
Adopted 10b5-1 plan Sep 22, 2026 10-Q Nov 9, 2026
What the company wrote
Michael Zagorsek, Chief Operating Officer, adopted a new trading plan on September 22, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until March 31, 2027 and provides for the sale of up to 1,188,139 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Aug 31, 2026 10-Q Nov 9, 2026
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on August 31, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until June 30, 2027 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 439,253 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Aug 24, 2026 10-Q Nov 9, 2026
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 24, 2026 (with the first trade under the new plan not to be made prior to December 1, 2026). The trading plan will be effective until February 28, 2027 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,171,059 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Aug 20, 2026 10-Q Nov 9, 2026
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 20, 2026 (with the first trade under the new plan not to be made prior to January 1, 2027). The trading plan will be effective until March 31, 2027 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 377,527 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Diana Sroka
Director
Adopted 10b5-1 plan May 28, 2026 10-Q Nov 9, 2026
What the company wrote
Diana Sroka, Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to August 27, 2026). The trading plan will be effective until June 30, 2027 and provides for the sale of 7,553 shares of Class A common stock, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan May 28, 2026 10-Q Aug 10, 2026
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to September 1, 2026). The trading plan will be effective until November 30, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,065,848 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Interim Chief Financial Officer, Chief Product Officer and Director
Adopted 10b5-1 plan May 28, 2026 10-Q Aug 10, 2026
What the company wrote
James M. Hom, Interim Chief Financial Officer, Chief Product Officer and Director, adopted a new trading plan on May 28, 2026 (with the first trade under the new plan not to be made prior to October 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 322,804 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Mar 10, 2026 10-Q May 11, 2026
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 10, 2026 (with the first trade under the new plan not to be made prior to June 16, 2026). The trading plan will be effective until August 31, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 1,083,222 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Eric Ball
Director
Adopted 10b5-1 plan Mar 9, 2026 10-Q Aug 10, 2026
What the company wrote
Eric Ball, Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to June 8, 2026). The trading plan will be effective until December 31, 2027 and provides for the sale of up to 150,000 shares of Class A common stock, provided that certain conditions are met.
•Eric Ball
Director
Adopted 10b5-1 plan Mar 9, 2026 10-Q May 11, 2026
What the company wrote
Eric Ball, Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to June 8, 2026). The trading plan will be effective until December 31, 2027 and provides for the sale of up to 150,000 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Mar 9, 2026 10-Q May 11, 2026
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 9, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until September 30, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 279,479 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Michael Zagorsek
Chief Operating Officer
Adopted 10b5-1 plan Mar 5, 2026 10-Q Aug 10, 2026
What the company wrote
Michael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 5, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met.
•Michael Zagorsek
Chief Operating Officer
Adopted 10b5-1 plan Mar 5, 2026 10-Q May 11, 2026
What the company wrote
Michael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 5, 2026 (with the first trade under the new plan not to be made prior to July 1, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Mar 3, 2026 10-Q Aug 10, 2026
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 3, 2026 (with the first trade under the new plan not to be made prior to June 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 354,048 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Mar 3, 2026 10-Q May 11, 2026
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 3, 2026 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 354,048 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Nov 24, 2025 10-K Mar 2, 2026
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on November 24, 2025 (with the first trade under the new plan not to be made prior to March 2, 2026). The trading plan will be effective until June 15, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B Common Stock and up to 931,899 shares of Class A Common Stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Nitesh Sharan
Chief Financial Officer
Adopted 10b5-1 plan Nov 20, 2025 10-K Mar 2, 2026
What the company wrote
Nitesh Sharan, Chief Financial Officer, adopted a new trading plan on November 20, 2025 (with the first trade under the new plan not to be made prior to March 2, 2026). The trading plan will be effective until December 31, 2026 and provides for the sale of up to 120,000 shares of Class A Common Stock issuable upon exercise of outstanding options and up to 140,754 shares of Class A Common Stock, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Nov 19, 2025 10-K Mar 2, 2026
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on November 19, 2025 (with the first trade under the new plan not to be made prior to April 1, 2026). The trading plan will be effective until June 30, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B Common Stock, up to 239,932 shares of Class A Common Stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Sep 23, 2025 10-Q Nov 10, 2025
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on September 23, 2025 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until March 31, 2026 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock and up to 301,297 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Aug 19, 2025 10-Q Nov 10, 2025
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 19, 2025 (with the first trade under the new plan not to be made prior to December 1, 2025). The trading plan will be effective until February 28, 2026 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 904,045 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Aug 19, 2025 10-Q Nov 10, 2025
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 19, 2025 (with the first trade under the new plan not to be made prior to January 2, 2026). The trading plan will be effective until March 31, 2026 and provides for the sale of up to 750,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock and up to 159,879 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Diana Sroka
Director
Adopted 10b5-1 plan Aug 12, 2025 10-Q Nov 10, 2025
What the company wrote
Diana Sroka, Director, adopted a new trading plan on August 12, 2025 (with the first trade under the new plan not to be made prior to November 11, 2025). The trading plan will be effective until May 31, 2026 and provides for the sale of up to 5,370 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan May 16, 2025 10-Q Aug 11, 2025
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on May 16, 2025 (with the first trade under the new plan not to be made prior to August 15, 2025). The trading plan will be effective until November 30, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 728,124 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Michael Zagorsek
Chief Operating Officer
Adopted 10b5-1 plan Mar 24, 2025 10-Q May 12, 2025
What the company wrote
Michael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 24, 2025 (with the first trade under the new plan not to be made prior to June 23, 2025). The trading plan will be effective until June 30, 2026 and provides for the sale of up to 179,888 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Mar 19, 2025 10-Q May 12, 2025
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 19, 2025 (with the first trade under the new plan not to be made prior to July 1, 2025). The trading plan will be effective until September 30, 2025 and provides for the sale of up to 800,000 shares of Mr. Hom’s 1,812,588 shares of Class B common stock and up to 3,815 shares of Class A common stock, and up to 69,686 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Mar 17, 2025 10-Q May 12, 2025
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 17, 2025 (with the first trade under the new plan not to be made prior to June 16, 2025). The trading plan will be effective until August 14, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock, up to 737,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Mar 11, 2025 10-Q May 12, 2025
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on March 11, 2025 (with the first trade under the new plan not to be made prior to June 10, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock, up to 562,850 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Timothy Stonehocker
Chief Technology Officer
Adopted 10b5-1 plan Dec 23, 2024 10-K Mar 11, 2025
What the company wrote
Timothy Stonehocker, Chief Technology Officer, adopted a new trading plan on December 23, 2024 (with the first trade under the new plan not to be made prior to March 24, 2025). The trading plan will be effective until February 15, 2026 and provides for the sale of up to 395,737 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Eric Ball
Director
Adopted 10b5-1 plan Dec 20, 2024 10-K Mar 11, 2025
What the company wrote
Eric Ball, Director, adopted a new trading plan on December 20, 2024 (with the first trade under the new plan not to be made prior to March 21, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 150,000 shares of Class A common stock, provided that certain conditions are met.
•Nitesh Sharan
Chief Financial Officer
Adopted 10b5-1 plan Dec 13, 2024 10-K Mar 11, 2025
What the company wrote
Nitesh Sharan, Chief Financial Officer, adopted a new trading plan on December 13, 2024 (with the first trade under the new plan not to be made prior to March 14, 2025). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 120,000 shares of Class A common stock issuable upon exercise of outstanding options and up to 121,506 shares of Class A common stock, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Nov 27, 2024 10-K Mar 11, 2025
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on November 27, 2024 (with the first trade under the new plan not to be made prior to March 1, 2025). The trading plan will be effective until June 15, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock and up to 737,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Nov 27, 2024 10-K Mar 11, 2025
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on November 27, 2024 (with the first trade under the new plan not to be made prior to April 1, 2025). The trading plan will be effective until June 30, 2025 and provides for the sale of up to 200,000 shares of Mr. Hom's 1,812,588 shares of Class B common stock, up to 3,815 shares of Class A common stock, and up to 29,534 shares of Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Aug 30, 2024 10-Q Nov 12, 2024
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on August 30, 2024 (with the first trade under the new plan not to be made prior to December 1, 2024). The trading plan will be effective until February 28, 2025 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer's 14,139,064 shares of Class B common stock, up to 461,026 shares of Class A common stock issuable upon exercise of outstanding options, and up to 461,026 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•Majid Emami
Chief Science Officer and Senior Vice President
Adopted 10b5-1 plan Aug 28, 2024 10-Q Nov 12, 2024
What the company wrote
Majid Emami, Chief Science Officer and Senior Vice President, adopted a new trading plan on August 28, 2024 (with the first trade under the new plan not to be made prior to December 1, 2024). The trading plan will be effective until May 31, 2025 and provides for the sale of up to 2,400,000 shares of Mr. Emami's 16,583,756 shares of Class B common stock, up to 666,748 shares of Class A common stock issuable upon exercise of outstanding options, and up to 254,067 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Aug 26, 2024 10-Q Nov 12, 2024
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on August 26, 2024 (with the first trade under the new plan not to be made prior to December 16, 2024). The trading plan will be effective until March 31, 2025 and provides for the sale of up to 400,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 191,857 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met
•Diana Sroka
Director
Adopted 10b5-1 plan Aug 12, 2024 10-Q Nov 12, 2024
What the company wrote
Diana Sroka, Director, adopted a modified trading plan on August 12, 2024 (with the first trade under the new plan not to be made prior to December 23, 2024). The trading plan will be effective until December 31, 2025 and provides for the sale of up to 9,604 shares of Ms. Sroka's Class A common stock issuable upon vesting and settlement of certain RSUs, provided that certain conditions are met.
•Eric Ball
Director
Adopted 10b5-1 plan Jun 28, 2024 10-Q Aug 9, 2024
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan May 31, 2024 10-Q Aug 9, 2024
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on May 31, 2024 (with the first trade under the new plan not to be made prior to September 18, 2024). The trading plan will be effective until December 15, 2024 and provides for the sale of up to 200,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 83,064 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met
•Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Mar 20, 2024 10-Q May 10, 2024
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on March 20, 2024 (with the first trade under the new plan not to be made prior to June 19, 2024). The trading plan will be effective until November 30, 2024 and provides for the sale of up to 2,400,000 shares of Dr. Mohajer’s 14,139,064 shares of Class B common stock, up to 833,435 shares of Class A common stock issuable upon exercise of outstanding options, and up to 467,500 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
•James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Mar 19, 2024 10-Q May 10, 2024
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on March 19, 2024 (with the first trade under the new plan not to be made prior to June 18, 2024). The trading plan will be effective until September 15, 2024 and provides for the sale of up to 200,000 shares of Mr. Hom’s 2,012,588 shares of Class B common stock and up to 97,706 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met
•Michael Zagorsek
Chief Operating Officer
Adopted 10b5-1 plan Mar 19, 2024 10-Q May 10, 2024
What the company wrote
Michael Zagorsek, Chief Operating Officer, adopted a new trading plan on March 19, 2024 (with the first trade under the new plan not to be made prior to June 18, 2024). The trading plan will be effective until January 31, 2026 and provides for the sale of up to 416,719 shares of Class A common stock issuable upon vesting and exercise of certain stock options, provided that certain conditions are met.
•Timothy Stonehocker
Chief Technology Officer
Adopted 10b5-1 plan Mar 6, 2024 10-Q May 10, 2024
What the company wrote
Timothy Stonehocker, Chief Technology Officer, adopted a new trading plan on March 6, 2024 (with the first trade under the new plan not to be made prior to June 5, 2024). The trading plan will be effective until August 12, 2024 and provides for the sale of up to 416,000 shares of Class A common stock, provided that certain conditions are met
Dr. Keyvan Mohajer
Chief Executive Officer and Director
Adopted 10b5-1 plan Dec 12, 2023 10-K Mar 1, 2024
What the company wrote
Dr. Keyvan Mohajer, Chief Executive Officer and Director, adopted a new trading plan on December 12, 2023 (with the first trade under the new plan not to be made prior to March 12, 2024). The trading plan will be effective until June 7, 2024 and provides for the sale of up to 1,800,000 shares of Dr. Mohajer’s 15,439,064 shares of Class B common stock. up to 833,435 shares of Class A common stock issuable upon exercise of outstanding options, and up to 355,000 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
Dr. Seyed Majid Emami
Chief Science Officer and Senior Vice President of Engineering
Adopted 10b5-1 plan Dec 8, 2023 10-K Mar 1, 2024
What the company wrote
Dr. Seyed Majid Emami, Chief Science Officer and Senior Vice President of Engineering, adopted a new trading plan on December 8, 2023 ( with the first trade under the new plan not to be made prior to March 8, 2024). The trading plan will be effective until November 30, 2024 and provides for the sale of up to 1,950,000 shares of Dr. Emami’s 18,033,756 shares of Class B common stock and up to 666,748 shares of Class A common stock issuable upon exercise of outstanding options, provided that certain conditions are met.
James M. Hom
Chief Product Officer and Director
Adopted 10b5-1 plan Dec 8, 2023 10-K Mar 1, 2024
What the company wrote
James M. Hom, Chief Product Officer and Director, adopted a new trading plan on December 8, 2023 ( with the first trade under the new plan not to be made prior to March 8, 2024). The trading plan will be effective until May 31, 2024 and provides for the sale of up to 2,000,000 shares of Mr. Hom’s 4,012,588 shares of Class B common stock and up to 100,000 shares of Class A common stock issuable upon vesting and settlement of certain RSUs and PSUs, provided that certain conditions are met.
Show the other 37 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 12, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Sep 17, 2026 DIANA SROKA
Director
1,552 $9K
Sep 15, 2026 ZAGORSEK MICHAEL
Officer
71,113 $460K
Sep 15, 2026 HOM JAMES MING
Officer, Director
38,730 $251K
Sep 15, 2026 EMAMI MAJID
Officer
38,730 $251K
Sep 15, 2026 MOHAJER KEYVAN
Officer, Director, 10% Stockholder
137,290 $888K
Aug 27, 2026 DIANA SROKA
Director
1,343 $9K
Jun 17, 2026 ZAGORSEK MICHAEL
Officer
64,994 $448K
Jun 17, 2026 HOM JAMES MING
Officer, Director
28,843 $199K
Jun 17, 2026 EMAMI MAJID
Officer
28,843 $199K
Jun 17, 2026 MOHAJER KEYVAN
Officer, Director, 10% Stockholder
126,540 $873K
Mar 23, 2026 DIANA SROKA
Director
1,343 $9K
Mar 20, 2026 ZAGORSEK MICHAEL
Officer
52,968 $364K
Mar 20, 2026 HOM JAMES MING
Officer, Director
31,019 $213K
Mar 20, 2026 EMAMI MAJID
Officer
31,019 $213K
Mar 20, 2026 MOHAJER KEYVAN
Officer, Director, 10% Stockholder
124,510 $856K
Mar 20, 2026 SHARAN NITESH
Officer
44,027 $303K
Dec 29, 2025 SEYED MAJID EMAMI
Officer, 10% Stockholder
32,741 $357K
Dec 23, 2025 DIANA SROKA
Director
1,343 $15K
Dec 22, 2025 ZAGORSEK MICHAEL
Officer
73,406 $809K
Dec 22, 2025 HOM JAMES MING
Officer, Director
42,600 $469K
Dec 22, 2025 EMAMI MAJID
Officer
42,600 $469K
Dec 22, 2025 MOHAJER KEYVAN
Officer, Director, 10% Stockholder
144,326 $1.6M
Dec 22, 2025 SHARAN NITESH
Officer
60,780 $670K
Show the other 15 notices

From the Form 144 XML filed with the SEC, since Dec 22, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SOUN/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.